158 related articles for article (PubMed ID: 23268010)
1. [Fluoropyrimidines with oxaliplatin(L-OHP) as an adjuvant chemotherapy for Stage III colon cancer].
Miyake Y; Ikeda K; Osawa H; Nagase H; Hoshi M; Doi T; Makari Y; Oshima S; Iijima S; Kurokawa E; Kikkawa N
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2161-3. PubMed ID: 23268010
[TBL] [Abstract][Full Text] [Related]
2. [Compliance with FOLFOX4 for Stage III colon cancer in the adjuvant setting].
Okazaki S; Sugawara K; Hashizume E; Abe M; Hagiwara M; Aiso T; Shirahata Y; Chin M; Suzuki A; Kuriya Y
Gan To Kagaku Ryoho; 2014 Jan; 41(1):59-63. PubMed ID: 24423953
[TBL] [Abstract][Full Text] [Related]
3. Is oxaliplatin combined with weekly bolus 5-fluorouracil and leucovorin an option for stage II and III colon cancer?
Twelves C
Nat Clin Pract Oncol; 2008 Feb; 5(2):72-3. PubMed ID: 18030299
[No Abstract] [Full Text] [Related]
4. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.
André T; Boni C; Mounedji-Boudiaf L; Navarro M; Tabernero J; Hickish T; Topham C; Zaninelli M; Clingan P; Bridgewater J; Tabah-Fisch I; de Gramont A;
N Engl J Med; 2004 Jun; 350(23):2343-51. PubMed ID: 15175436
[TBL] [Abstract][Full Text] [Related]
5. Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea.
Kim JY; Kim YJ; Lee KW; Lee JS; Kim DW; Kang SB; Lee HS; Jang NY; Kim JS; Kim JH
Jpn J Clin Oncol; 2013 Feb; 43(2):132-8. PubMed ID: 23204187
[TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.
Kuebler JP; Wieand HS; O'Connell MJ; Smith RE; Colangelo LH; Yothers G; Petrelli NJ; Findlay MP; Seay TE; Atkins JN; Zapas JL; Goodwin JW; Fehrenbacher L; Ramanathan RK; Conley BA; Flynn PJ; Soori G; Colman LK; Levine EA; Lanier KS; Wolmark N
J Clin Oncol; 2007 Jun; 25(16):2198-204. PubMed ID: 17470851
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial.
Tournigand C; André T; Bonnetain F; Chibaudel B; Lledo G; Hickish T; Tabernero J; Boni C; Bachet JB; Teixeira L; de Gramont A
J Clin Oncol; 2012 Sep; 30(27):3353-60. PubMed ID: 22915656
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials.
Gallois C; Shi Q; Pederson LD; André T; Iveson TJ; Sobrero AF; Alberts S; de Gramont A; Meyerhardt JA; George T; Schmoll HE; Souglakos I; Harkin A; Labianca R; Sinicrope FA; Oki E; Shields AF; Boukovinas I; Kerr R; Lonardi S; Yothers G; Yoshino T; Goldberg RM; Taieb J; Papamichael D
J Clin Oncol; 2024 Jul; 42(19):2295-2305. PubMed ID: 38547438
[TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.
Taieb J; Tabernero J; Mini E; Subtil F; Folprecht G; Van Laethem JL; Thaler J; Bridgewater J; Petersen LN; Blons H; Collette L; Van Cutsem E; Rougier P; Salazar R; Bedenne L; Emile JF; Laurent-Puig P; Lepage C;
Lancet Oncol; 2014 Jul; 15(8):862-73. PubMed ID: 24928083
[TBL] [Abstract][Full Text] [Related]
10. The toxicity and efficacy of Nordic-FLOX regimen as adjuvant treatment of stage III colon cancer.
Demir L; Somali I; Oktay Tarhan M; Erten C; Ellidokuz H; Can A; Dirican A; Vedat Bayoglu I
J BUON; 2011; 16(4):682-8. PubMed ID: 22331722
[TBL] [Abstract][Full Text] [Related]
11. [Progression of adjuvant chemotherapy for colon cancer].
He YJ; Dong QM; Li YH
Ai Zheng; 2005 Dec; 24(12):1546-9. PubMed ID: 16351811
[TBL] [Abstract][Full Text] [Related]
12. [Anaphylactic reaction to oxaliplatin--a case of colon cancer].
Sagawa T; Sato Y; Abe S; Okuda T; Araki N; Takahari D; Okamoto T; Takayama T; Kato J; Niitsu Y
Gan To Kagaku Ryoho; 2006 Dec; 33(13):2093-6. PubMed ID: 17197761
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in The Netherlands.
van Gils CW; Koopman M; Mol L; Redekop WK; Uyl-de Groot CA; Punt CJ
Acta Oncol; 2012 Jan; 51(1):57-64. PubMed ID: 22122695
[TBL] [Abstract][Full Text] [Related]
14. [Should adjuvant chemotherapy be also used in Dukes stage B2 colon cancer?].
Porschen R
Z Gastroenterol; 1996 Sep; 34(9):549-51. PubMed ID: 8975491
[No Abstract] [Full Text] [Related]
15. Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans.
Aspinall SL; Good CB; Zhao X; Cunningham FE; Heron BB; Geraci M; Passero V; Stone RA; Smith KJ; Rogers R; Shields J; Sartore M; Boyle DP; Giberti S; Szymanski J; Smith D; Ha A; Sessions J; Depcinski S; Fishco S; Molina I; Lepir T; Jean C; Cruz-Diaz L; Motta J; Calderon-Vargas R; Maland J; Keefe S; Tague M; Leone A; Glovack B; Kaplan B; Cosgriff S; Kaster L; Tonnu-Mihara I; Nguyen K; Carmichael J; Clifford L; Lu K; Chatta G
BMC Cancer; 2015 Feb; 15():62. PubMed ID: 25884851
[TBL] [Abstract][Full Text] [Related]
16. [Clinical observation of XELOX (Capecitabine puls Oxaliplatin): an adjuvant chemotherapy regimen used in stage III colorectal cancer].
Diao C; Cheng RC; Zhang JM; Wei XP; Su YJ; Liu QY; Xu JB
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):147-50. PubMed ID: 18646702
[TBL] [Abstract][Full Text] [Related]
17. Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07.
Land SR; Kopec JA; Cecchini RS; Ganz PA; Wieand HS; Colangelo LH; Murphy K; Kuebler JP; Seay TE; Needles BM; Bearden JD; Colman LK; Lanier KS; Pajon ER; Cella D; Smith RE; O'Connell MJ; Costantino JP; Wolmark N
J Clin Oncol; 2007 Jun; 25(16):2205-11. PubMed ID: 17470850
[TBL] [Abstract][Full Text] [Related]
18. Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis.
Sanoff HK; Carpenter WR; Freburger J; Li L; Chen K; Zullig LL; Goldberg RM; Schymura MJ; Schrag D
Cancer; 2012 Sep; 118(17):4309-20. PubMed ID: 22294436
[TBL] [Abstract][Full Text] [Related]
19. Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial).
Kotaka M; Yoshino T; Oba K; Shinozaki K; Touyama T; Manaka D; Matsui T; Ishigure K; Hasegawa J; Inoue K; Goto K; Sakamoto J; Saji S; Ohtsu A; Watanabe T
Cancer Chemother Pharmacol; 2015 Jul; 76(1):75-84. PubMed ID: 25983021
[TBL] [Abstract][Full Text] [Related]
20. [The present status of CapeOX as adjuvant chemotherapy for colorectal cancer].
Ishii K; Kanamoto A; Miyanaga S; Noto M; Takeda T; Tani T; Yagi M
Gan To Kagaku Ryoho; 2015 Mar; 42(3):319-22. PubMed ID: 25812500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]